Vesalio NeVa VS for Symptomatic Cerebral Vasospasm Following aSAH (The VITAL Study)

计划入组 30 人 · 首次发布于 2018 年 8 月 2 日

The Vesalio NeVa Stent Retriever Study for Treatment of Large Vessel Occlusion Strokes

计划入组 150 人 · 首次发布于 2019 年 4 月 25 日

The Vesalio NeVa Stent Retriever Registry Study for Treatment of Large Vessel Occlusion Strokes

计划入组 400 人 · 首次发布于 2019 年 4 月 25 日

Obesity (Resalis Therapeutics)

Oncologic Project (Resalis Therapeutics)

Metabolic associated fatty liver disease therapy(Resalis therapeutics)

Vesalio S.A.

Peru

Vesalion s.r.o.

Czech Republic

VESALIUS MEDICAL TECHNOLOGIES

Belgium

Vesalio Secures CE Mark for Neurovascular Devices Targeting Cerebral Vasospasm and Stroke Treatment

Vesalio's enVast Thrombectomy System NATURE Trial Selected as Late-Breaker at ESC Congress 2026

Sanofi Invests in Resalis Therapeutics' miRNA-22 Inhibitor for Obesity Treatment